| Literature DB >> 26782640 |
Keliang Gao1,2, Xiaomeng Huang1,3,4, Chi-Ling Chiang1,4, Xinmei Wang1, Lingqian Chang1, Pouyan Boukany1, Guido Marcucci4, Robert Lee2, Ly James Lee1,3,5.
Abstract
Nanochannel electroporation (NEP) was applied to deliver precise dosages of myeloid cell leukemia-1 (Mcl-1)-specific siRNA and molecular beacons to two types of acute myeloid leukemia (AML) cells, FMS-like tyrosine kinase-3 wild-type (WT) and internal tandem duplications (ITD) type at the single-cell level. NEP, together with single-cell quantitative reverse transcription PCR, led to an observation showing nearly 20-folds more Mcl-1 siRNA than MCL1 mRNA were required to induce cell death for both cell lines and patient blasts, i.e., ~8,800 siRNAs for ~500 ± 50 mRNAs in ITD cells and ~6,000 siRNAs for ~300 ± 50 mRNAs in WT cells. A time-lapse study revealed that >75% MCL1 mRNA was downregulated within 1 hour after delivery of a small amount of siRNA. However, additional siRNA was required to inhibit the newly transcribed mRNA for >12 hours until the cell lost its ability of self-protection recovery. A multidelivery strategy of low doses and short delivery interval, which require 77% less siRNA and has the potential of lower side effects and clinical cost, was as effective as a single high-dose siRNA delivery. Our method provides a viable analytical tool to investigate gene silencing at the single-cell level for oligonucleotide-based therapy.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26782640 PMCID: PMC4881776 DOI: 10.1038/mt.2016.6
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 11.454